Welcome to Dwaey, specifically on Nevirapine page.
This medicine contains important and useful components, as it consists of
Nevirapine is available in the market in concentration.
Nevirapine
Before initiating Nevirapine, it is essential to consult a healthcare provider due to several precautions associated with its use. Nevirapine is an antiretroviral medication primarily used in the treatment of HIV. The following considerations must be noted:
- Liver function: Nevirapine can cause liver toxicity, which can be severe and life-threatening. It is particularly important to monitor liver function, especially in patients with pre-existing liver conditions (such as hepatitis or cirrhosis). Liver enzyme levels should be checked regularly during the treatment.
- Hypersensitivity reactions: Nevirapine may cause severe skin rashes, fever, and flu-like symptoms. Stevens-Johnson Syndrome or toxic epidermal necrolysis are rare but serious adverse effects. Immediate discontinuation of the medication is required if any severe skin reactions occur.
- Pregnancy: While Nevirapine is used in HIV treatment during pregnancy, it should only be prescribed after careful assessment of the risks and benefits. It is not recommended in the first trimester unless absolutely necessary due to the risk of liver toxicity.
- Drug interactions: Nevirapine can interact with other medications, especially those that affect liver enzymes (e.g., CYP450 inducers/inhibitors). Dose adjustments and careful monitoring of interactions are critical.
- Immune reconstitution syndrome: In some patients with advanced HIV, Nevirapine can trigger immune reconstitution inflammatory syndrome (IRIS), a reaction where the immune system becomes overly active after starting therapy. Patients should be closely monitored during early treatment.
Nevirapine is prescribed primarily for the treatment of HIV-1 infection. Its indications include:
- HIV-1 infection: It is a reverse transcriptase inhibitor used as part of combination therapy for the treatment of HIV. Nevirapine helps to reduce the viral load and prevent the progression to AIDS in HIV-positive individuals.
- Prevention of mother-to-child transmission: It may be used as part of a regimen to prevent the transmission of HIV from mother to child during labor and delivery.
- Post-exposure prophylaxis: Nevirapine is also used in some cases for post-exposure prophylaxis (PEP) to reduce the likelihood of HIV infection after possible exposure to the virus, such as in healthcare workers who experience needlestick injuries.
Nevirapine should not be used in certain situations due to the risk of severe adverse reactions. Contraindications include:
- Severe liver disease: Patients with moderate to severe hepatic impairment (e.g., cirrhosis, hepatitis) should not use Nevirapine, as it may worsen liver function or lead to life-threatening liver failure.
- History of severe hypersensitivity reactions: Patients who have experienced severe skin reactions, such as Stevens-Johnson syndrome or toxic epidermal necrolysis, after using Nevirapine or similar drugs should not take it again.
- Co-infection with Hepatitis C or B: Co-infection with hepatitis B or hepatitis C significantly increases the risk of hepatotoxicity. Nevirapine should be avoided in these cases unless the benefits outweigh the risks, and liver function must be monitored closely.
- First trimester of pregnancy: Nevirapine is contraindicated in the first trimester of pregnancy due to concerns about liver toxicity and its impact on the fetus.
Common and severe side effects associated with Nevirapine include:
- Liver toxicity: The most serious side effect of Nevirapine is hepatotoxicity, which can result in hepatitis, liver failure, and death in severe cases. Liver function tests should be conducted before starting therapy and regularly monitored during treatment.
- Skin reactions: Rashes, which may progress to severe reactions like Stevens-Johnson syndrome or toxic epidermal necrolysis, are common. Patients should be monitored for any signs of skin irritation or blistering.
- Gastrointestinal symptoms: Nausea, vomiting, diarrhea, and abdominal pain are common, especially during the initiation of therapy. These symptoms generally subside over time.
- CNS effects: Some patients experience headache, dizziness, or fatigue as side effects of Nevirapine therapy.
- Immune reconstitution inflammatory syndrome (IRIS): This syndrome occurs when the immune system begins to recover, potentially leading to worsening of symptoms related to HIV-associated infections. It can manifest as fever, swollen lymph nodes, and inflammation.
2
Nevirapine is a non-nucleoside reverse transcriptase inhibitor (NNRTI). It works by binding directly to the reverse transcriptase enzyme, which is essential for the replication of HIV. By inhibiting this enzyme, Nevirapine prevents the conversion of HIV RNA into DNA, thus inhibiting the replication of the virus. This leads to:
- Reduced viral replication: By inhibiting the reverse transcriptase, Nevirapine reduces the viral load in the body and slows the progression of the HIV infection.
- Improved immune function: As the viral load decreases, the immune system can recover and function better, reducing the risk of opportunistic infections and helping to prevent the progression to AIDS.
Nevirapine is metabolized by the liver enzyme system CYP450, particularly CYP3A4. Therefore, it has several drug interactions, including:
- CYP450 inducers: Medications that increase liver enzyme activity (e.g., rifampicin, phenytoin, carbamazepine) can reduce Nevirapine levels, decreasing its effectiveness. Dosage adjustments may be necessary.
- CYP450 inhibitors: Drugs that inhibit CYP450 enzymes (e.g., ketoconazole, clarithromycin) may increase Nevirapine levels, leading to an increased risk of toxicity, particularly liver damage. Close monitoring is required.
- Protease inhibitors: The combination of Nevirapine with protease inhibitors like lopinavir/ritonavir or atazanavir may result in either increased side effects or reduced therapeutic efficacy, depending on the specific drugs used. It is often prescribed with other reverse transcriptase inhibitors (e.g., lamivudine, abacavir).
- Other HIV medications: When used in combination with other HIV drugs, the dosing schedules must be carefully coordinated to avoid adverse interactions and ensure optimal viral suppression.
- Oral contraceptives: Nevirapine may decrease the effectiveness of oral contraceptives, potentially leading to unintended pregnancies. Additional or alternative methods of contraception should be considered.
For adults with HIV-1 infection, the typical dosage of Nevirapine is as follows:
- Initial dosing: The recommended starting dose is typically 200 mg orally once daily for the first 14 days to assess tolerance.
- Maintenance dosing: After 14 days, the dose is increased to 200 mg twice daily. Doses may be adjusted based on patient tolerance, other medications being taken, and liver function.
- Combination therapy: Nevirapine is used in combination with other antiretroviral medications, including nucleoside reverse transcriptase inhibitors (NRTIs) and other NNRTIs.
For children, the dosing of Nevirapine is based on age and body weight.
- For children 2 years and older: The recommended dose is usually 4 mg/kg once daily for the first 14 days, followed by 4 mg/kg twice daily for maintenance.
- For children under 2 years: The use of Nevirapine in children under 2 years is limited and should only be prescribed under the supervision of a healthcare provider with expertise in pediatric HIV care.
As with all medications, it is essential for patients and caregivers to consult a healthcare provider for personalized dosing recommendations and monitoring.
Nevirapine does not require dose adjustment in renal impairment, as it is primarily metabolized by the liver. However, for patients with severe renal dysfunction, careful monitoring should be conducted, especially if they are on other medications that affect kidney function.